New chemo formula may reduce Alcohol-Like reactions in breast cancer patients
NCT ID NCT06537752
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study observes over 1,000 breast cancer patients receiving a special version of the chemotherapy drug docetaxel that contains no ethanol (alcohol). The goal is to see how often patients experience alcohol-like symptoms such as flushing or dizziness during or shortly after treatment. Researchers hope this information will help make chemotherapy safer and more tolerable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
non-ethanol formulation docetaxel
What this could lead to
If successful, this study could help doctors better manage side effects during breast cancer chemotherapy, potentially improving patient comfort.
What could go wrong
This is an observational study, not a treatment trial. It won't test whether the drug works against cancer, only how often ethanol-related symptoms occur. Results may not change current practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chung-Ang University Hospital
RECRUITINGSeoul, 06973, South Korea
Contact
-
Uijeongbu Eulji Medical Center, Eulji University
NOT_YET_RECRUITINGUijeongbu-si, 11759, South Korea
Contact